Jointown Pharmaceutical Group Co., Ltd (SHA:600998)

SHA:600998 Revenue

Jointown Pharmaceutical Group had revenue of 42.50B CNY in the quarter ending June 30, 2026, with 8.71% growth. This brings the company's total for the last twelve months to 167.56B, up 7.59% year-over-year. In the year 2025, Jointown Pharmaceutical Group had annual revenue of 161.39B with 6.31% growth. That makes Jointown Pharmaceutical Group the 582nd largest company in the world by revenue and 46th in China.

• Revenue (ttm): 167.56B
• Revenue Growth: +7.59%
• P/S Ratio: 0.15
• Revenue / Employee: 5.61M
• Employees: 29,862
• Market Cap: 24.53B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Distribution 156.75B 95.2%
• Industrial 4.22B 2.6%
• Retail 2.88B 1.7%
• Healthcare Segment 465.80M 0.3%
• Other Segment 291.45M 0.2%

By Geography

Chart

• Eastern China 48.31B 29.9%
• Central China 35.53B 22.0%
• North China 28.22B 17.5%
• Southwest China 14.47B 9.0%
• Northwest China 14.10B 8.7%
• South China 13.17B 8.2%
• North East China 7.37B 4.6%
• Other Areas 219.83M 0.1%

Fiscal year ended Dec 31, 2025 See the full SHA:600998 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	161.39B	9.58B	6.31%
Dec 31, 2024	151.81B	1.67B	1.11%
Dec 31, 2023	150.14B	9.72B	6.92%
Dec 31, 2022	140.42B	18.02B	14.72%
Dec 31, 2021	122.41B	11.55B	10.42%

Data Source: S&P Global Market Intelligence Last updated: Aug 25, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 20, 2026

Data Sources Report a data error